pancreatic cancer

First mRNA pancreatic cancer vaccine patient disease-free

Seven years after she became the world's first person to receive a personalized mRNA vaccine for pancreatic cancer, Donna Gustafson shows no evidence of the disease that was expected to kill her, NPR reported on Nov. 2. Her story comes…

Harvard study finds way to extend KRAS drug response in pancreatic cancer

Researchers at Harvard Medical School have identified a way to transform the short-lived benefits of KRAS inhibitors in pancreatic cancer into lasting remissions by enlisting CD4 T-cell immunity through an IL-21 mimetic strategy. The findings, published Wednesday in Cell, address…